2BB score and signals
Trevi Therapeutics, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 60 | Strong |
| Risk | 34 | Low |
Company facts
| Headquarters | New Haven, Connecticut, United States |
| Founded | 2011 |
| Employees | 34 |
| 52-week range | $5.53 – $19.26 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.1325 | — | $0.00 |
| 2026-08-06 | — | -0.1125 | — | $0.00 |
| 2026-05-06 | — | -0.1173 | — | $0.00 |
| 2026-03-16 | — | -0.1001 | — | $0.00 |
